Anakinra for severe forms of COVID-19: a cohort study. En savoir plus sur Anakinra for severe forms of COVID-19: a cohort study.
2010 French SPILF-AFSSAPS guiding criteria for Streptococcuspneumoniae acute community-acquired pneumonia: Evaluation in patients of the PACSCAN-ESCAPED cohort. En savoir plus sur 2010 French SPILF-AFSSAPS guiding criteria for Streptococcuspneumoniae acute community-acquired pneumonia: Evaluation in patients of the PACSCAN-ESCAPED cohort.
Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience. En savoir plus sur Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience.
Susceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities? En savoir plus sur Susceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities?
Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases. En savoir plus sur Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases.
Fatal haemoptysis after a bilateral lung retransplantation 4 years ago. En savoir plus sur Fatal haemoptysis after a bilateral lung retransplantation 4 years ago.
A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial. En savoir plus sur A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial.
[Factors associated with poor acceptance of illness in patients with COPD]. En savoir plus sur [Factors associated with poor acceptance of illness in patients with COPD].
Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers? En savoir plus sur Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?
